BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
9.90
-0.18 (-1.79%)
At close: Sep 5, 2025, 4:00 PM
10.23
+0.33 (3.33%)
After-hours: Sep 5, 2025, 7:59 PM EDT

BBOT Statistics

Total Valuation

BBOT has a market cap or net worth of $855.86 million. The enterprise value is $727.29 million.

Market Cap855.86M
Enterprise Value 727.29M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

BBOT has 86.45 million shares outstanding.

Current Share Class 86.45M
Shares Outstanding 86.45M
Shares Change (YoY) n/a
Shares Change (QoQ) +38.82%
Owned by Insiders (%) 5.24%
Owned by Institutions (%) n/a
Float 45.52M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 7.04
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.02.

Current Ratio 5.22
Quick Ratio 4.86
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -76.43%
Revenue Per Employee n/a
Profits Per Employee -$1.41M
Employee Count62
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 54.97
Average Volume (20 Days) 190,089

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -94.77M
Pretax Income n/a
Net Income -87.50M
EBITDA -94.55M
EBIT -94.77M
Earnings Per Share (EPS) -$268.56
Full Income Statement

Balance Sheet

The company has $131.40 million in cash and $2.83 million in debt, giving a net cash position of $128.56 million or $1.49 per share.

Cash & Cash Equivalents 131.40M
Total Debt 2.83M
Net Cash 128.56M
Net Cash Per Share $1.49
Equity (Book Value) 121.49M
Book Value Per Share -403.34
Working Capital 115.10M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$80.90 million and capital expenditures -$414,000, giving a free cash flow of -$81.31 million.

Operating Cash Flow -80.90M
Capital Expenditures -414,000
Free Cash Flow -81.31M
FCF Per Share -$0.94
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BBOT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -10.22%
FCF Yield -9.50%

Analyst Forecast

The average price target for BBOT is $24.00, which is 142.42% higher than the current price. The consensus rating is "Buy".

Price Target $24.00
Price Target Difference 142.42%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1